UniPharma Stock Forecast - Naive Prediction
| 6621 Stock | TWD 13.10 0.05 0.38% |
The Naive Prediction forecasted value of UniPharma Co on the next trading day is expected to be 13.69 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 4.49. UniPharma Stock Forecast is based on your current time horizon.
As of today the value of rsi of UniPharma's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using UniPharma hype-based prediction, you can estimate the value of UniPharma Co from the perspective of UniPharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of UniPharma Co on the next trading day is expected to be 13.69 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 4.49. UniPharma after-hype prediction price | TWD 13.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
UniPharma |
UniPharma Additional Predictive Modules
Most predictive techniques to examine UniPharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for UniPharma using various technical indicators. When you analyze UniPharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
UniPharma Naive Prediction Price Forecast For the 25th of January
Given 90 days horizon, the Naive Prediction forecasted value of UniPharma Co on the next trading day is expected to be 13.69 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.03, and the sum of the absolute errors of 4.49.Please note that although there have been many attempts to predict UniPharma Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that UniPharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
UniPharma Stock Forecast Pattern
| Backtest UniPharma | UniPharma Price Prediction | Buy or Sell Advice |
UniPharma Forecasted Value
In the context of forecasting UniPharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. UniPharma's downside and upside margins for the forecasting period are 12.09 and 15.29, respectively. We have considered UniPharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of UniPharma stock data series using in forecasting. Note that when a statistical model is used to represent UniPharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 74.1472 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1152 |
| MAPE | Mean absolute percentage error | 0.0093 |
| SAE | Sum of the absolute errors | 4.4925 |
Predictive Modules for UniPharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as UniPharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.UniPharma After-Hype Price Prediction Density Analysis
As far as predicting the price of UniPharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in UniPharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of UniPharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
UniPharma Estimiated After-Hype Price Volatility
In the context of predicting UniPharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on UniPharma's historical news coverage. UniPharma's after-hype downside and upside margins for the prediction period are 11.50 and 14.70, respectively. We have considered UniPharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
UniPharma is not too volatile at this time. Analysis and calculation of next after-hype price of UniPharma is based on 3 months time horizon.
UniPharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as UniPharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading UniPharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with UniPharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 1.60 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.10 | 13.10 | 0.00 |
|
UniPharma Hype Timeline
UniPharma is presently traded for 13.10on Taiwan OTC Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. UniPharma is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.21%. %. The volatility of related hype on UniPharma is about 0.0%, with the expected price after the next announcement by competition of 13.10. The company has Price-to-Book (P/B) ratio of 1.23. In the past many companies with similar price-to-book ratios have beat the market. UniPharma recorded a loss per share of 1.57. The entity had not issued any dividends in recent years. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of UniPharma to cross-verify your projections.UniPharma Related Hype Analysis
Having access to credible news sources related to UniPharma's direct competition is more important than ever and may enhance your ability to predict UniPharma's future price movements. Getting to know how UniPharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how UniPharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 7607 | 7607 | 0.00 | 0 per month | 0.00 | (0.06) | 4.63 | (4.65) | 13.34 | |
| 4183 | EPS Bio Technology | 0.00 | 0 per month | 0.00 | (0.16) | 2.64 | (2.35) | 8.43 | |
| 7595 | Pharmigene | 0.00 | 0 per month | 0.00 | (0.07) | 4.12 | (3.82) | 7.95 | |
| 6661 | Welgene Biotech CoLtd | 0.00 | 0 per month | 0.00 | (0.11) | 2.33 | (2.05) | 7.33 | |
| 6797 | Taiwan Advanced Nanotech | 0.00 | 0 per month | 3.35 | (0.01) | 4.65 | (7.10) | 22.74 | |
| 4115 | Sunder Biomedical Tech | 0.00 | 0 per month | 1.49 | (0) | 3.95 | (3.57) | 8.68 | |
| 6734 | iXensor Co | 0.00 | 0 per month | 0.00 | (0.12) | 4.13 | (4.76) | 15.82 | |
| 7561 | Bioray Biotech Co | 0.00 | 0 per month | 2.24 | 0.13 | 6.97 | (4.31) | 14.96 | |
| 6758 | A SPINE Asia Co | 0.00 | 0 per month | 0.00 | (0.10) | 1.62 | (3.97) | 8.78 | |
| 1781 | Health Life Co | 0.00 | 0 per month | 0.00 | (0.05) | 0.91 | (1.33) | 10.60 |
Other Forecasting Options for UniPharma
For every potential investor in UniPharma, whether a beginner or expert, UniPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. UniPharma Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in UniPharma. Basic forecasting techniques help filter out the noise by identifying UniPharma's price trends.UniPharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with UniPharma stock to make a market-neutral strategy. Peer analysis of UniPharma could also be used in its relative valuation, which is a method of valuing UniPharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
UniPharma Market Strength Events
Market strength indicators help investors to evaluate how UniPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading UniPharma shares will generate the highest return on investment. By undertsting and applying UniPharma stock market strength indicators, traders can identify UniPharma Co entry and exit signals to maximize returns.
UniPharma Risk Indicators
The analysis of UniPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in UniPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting unipharma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.16 | |||
| Semi Deviation | 1.32 | |||
| Standard Deviation | 1.62 | |||
| Variance | 2.64 | |||
| Downside Variance | 2.88 | |||
| Semi Variance | 1.75 | |||
| Expected Short fall | (1.44) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for UniPharma
The number of cover stories for UniPharma depends on current market conditions and UniPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that UniPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about UniPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
UniPharma Short Properties
UniPharma's future price predictability will typically decrease when UniPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of UniPharma Co often depends not only on the future outlook of the potential UniPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. UniPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Average Daily Volume Last 10 Day | 303.9k | |
| Average Daily Volume In Three Month | 137.16k |
Additional Tools for UniPharma Stock Analysis
When running UniPharma's price analysis, check to measure UniPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UniPharma is operating at the current time. Most of UniPharma's value examination focuses on studying past and present price action to predict the probability of UniPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UniPharma's price. Additionally, you may evaluate how the addition of UniPharma to your portfolios can decrease your overall portfolio volatility.